Medicine & Health

Washington University in St. Louis will begin construction in March on what will be one of the largest neuroscience research buildings in the country. Located on the School of Medicine campus, the 11-story, state-of-the-art research facility will merge, cultivate and advance some of the world’s leading neuroscience research.

Soon after a novel coronavirus first appeared, School of Medicine researchers, doctors and staff began preparing for a possible outbreak. Infectious disease physicians started planning how to respond, and researchers got to work finding drugs or vaccines for COVID-19.

Sara Miller, WashU alum, founded SODA, an organ donation advocacy group on campus to educate students.

Parents’ social isolation was linked to self-reported poorer health not only for themselves but also for their adolescent children, finds a study from the Brown School at Washington University in St. Louis.

A mouse study from Washington University School of Medicine in St. Louis suggests a type of immune cell may play a surprising role in the structure and rhythm of the heart.

The School of Medicine’s Healthy Work Center facilitates research to promote the health of working-age people by focusing on topics such as diet and exercise, cancer prevention and injury avoidance. It’s a rebooted version of the Occupational Safety and Health Research Lab.

Members of the School of Medicine lab of Matthew Ciorba, MD, have identified a way to make radiation therapy for colorectal cancer more effective by inhibiting a protein found in cancer cells in the gut.

Two physicians from the University of Ghana recently wrapped up a monthlong visit to Washington University in St. Louis as part of the Africa Initiative’s faculty exchange.

Racial and ethnic minority children and adolescents with cancer have a higher risk of death than non-Hispanic white children and adolescents, with evidence for larger disparities in survival for more treatable cancers, finds a new study from the Brown School at Washington University in St. Louis.

A drug strategy aimed at revving up the immune system and boosting a type of immune cell known as natural killer cells appears, at least in mice, to effectively treat the skin condition eczema. A team led by the School of Medicine’s Brian S. Kim, MD, is behind the strategy.